SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-355847
Filing Date
2017-11-29
Accepted
2017-11-29 17:18:58
Documents
3
Group Members
KEVIN FERROVATERA HEALTHCARE PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d444250dsc13da.htm SC 13D/A 61541
2 EX-4 d444250dex994.htm EX-99.4 68463
3 EX-5 d444250dex995.htm EX-99.5 42895
  Complete submission text file 0001193125-17-355847.txt   174674
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
MELINTA THERAPEUTICS, INC. /NEW/ (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86624 | Film No.: 171229307
SIC: 2834 Pharmaceutical Preparations

Mailing Address 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022 212-590-2950
VATERA HOLDINGS LLC (Filed by) CIK: 0001548880 (see all company filings)

IRS No.: 208894647 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A